These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4746851)

  • 1. [Letter: Tolbutamide therapy of fatty liver?].
    Mehnert H
    Med Klin; 1973 Sep; 68(38):1240. PubMed ID: 4746851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolbutamide therapy of fatty liver].
    Wildhirt E
    Med Welt; 1971 Mar; 10():383-7. PubMed ID: 5549137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of tolbutamide on the fatty liver of diabetics].
    Lange HJ; Knick B; Kössling FK; Kremer GJ; Beringer A; Hrabal ; Irsigler K; Thaler H
    Dtsch Med Wochenschr; 1968 Jul; 93(29):1412-6. PubMed ID: 5658748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behaviour of liver function tests and enzymes in various stages of fatty liver under long-term treatment with Tolbutamide].
    Schmitt W
    Med Welt; 1968 Apr; 16():1060-5. PubMed ID: 5703103
    [No Abstract]   [Full Text] [Related]  

  • 6. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W; Bchardt U
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Tolbutamide and achondroplasia.
    Blizzard RM; McKusick VA
    JAMA; 1974 Jun; 228(11):1368. PubMed ID: 4406604
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of tolbutamide on the diabetic fatty liver.
    Beringer A; Hrabal I; Irsigler K; Thaler H
    Ger Med Mon; 1968 Dec; 13(12):595-8. PubMed ID: 4898499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatic steatosis in diabetics. The place of dolipol in its treatment].
    Journ Annu Diabetol Hotel Dieu; 1968; 9():423-6. PubMed ID: 5748223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current problems of fatty liver].
    Knick B
    Dtsch Med J; 1968 May; 19(10):389-94. PubMed ID: 4889933
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations apropos of severe and prolonged hypoglycemia occurring in an aged patient under treatment with sulfanylurea].
    Barbieri R; Michetti A
    Policlinico Prat; 1967 Sep; 74(37):1263-9. PubMed ID: 5615909
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Phenylbutazone-tolbutamide drug interaction.
    Tannenbaum H; Anderson LG; Soeldner JS
    N Engl J Med; 1974 Feb; 290(6):344. PubMed ID: 4809290
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of chronic inflammatory liver diseases].
    Vetter K; Kettler LH; Kaschube I; Lüder W
    Dtsch Z Verdau Stoffwechselkr; 1966 Dec; 26(3):121-9. PubMed ID: 5998373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe hypoglycemia due to Dirastan (tolbutamide) in a diabetic with chronic renal failure].
    Bures J; Fixa B; Kaut V; Herout V; Hrncír Z
    Vnitr Lek; 1982 Jul; 28(7):678-84. PubMed ID: 7112992
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoglycaemia induced by azapropazone-tolbutamide interaction.
    Andreasen PB; Simonsen K; Brocks K; Dimo B; Bouchelouche P
    Br J Clin Pharmacol; 1981 Oct; 12(4):581-3. PubMed ID: 7295492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
    Ziegelasch HJ
    Z Gesamte Inn Med; 1972 Jan; 27(2):63-6. PubMed ID: 5022999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.